memantine has been researched along with Ocular Hypertension in 5 studies
Ocular Hypertension: A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine, using electrophysiological measures of visual system function, whether oral daily dosing of memantine is both safe and effective to reduce the injury associated with experimental glaucoma in primates." | 7.72 | Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures. ( Chun, T; Hare, WA; Lai, RK; Ruiz, G; Ton, H; Wheeler, L; WoldeMussie, E, 2004) |
| "To determine, using anatomic measurements, whether daily oral dosing with memantine is both safe and effective to reduce the injury associated with experimental glaucoma in primates." | 7.72 | Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures. ( Feldmann, B; Hare, WA; Ruiz, G; Ton, H; Weinreb, RN; Wheeler, L; Wijono, M; WoldeMussie, E; Zangwill, L, 2004) |
| "Retinal ischemia increased vitreous concentrations of glutamate and glycine." | 7.70 | Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. ( Bach, M; Feuerstein, TJ; Knörle, R; Lagrèze, WA, 1998) |
| "To determine, using electrophysiological measures of visual system function, whether oral daily dosing of memantine is both safe and effective to reduce the injury associated with experimental glaucoma in primates." | 3.72 | Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures. ( Chun, T; Hare, WA; Lai, RK; Ruiz, G; Ton, H; Wheeler, L; WoldeMussie, E, 2004) |
| "To determine, using anatomic measurements, whether daily oral dosing with memantine is both safe and effective to reduce the injury associated with experimental glaucoma in primates." | 3.72 | Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures. ( Feldmann, B; Hare, WA; Ruiz, G; Ton, H; Weinreb, RN; Wheeler, L; Wijono, M; WoldeMussie, E; Zangwill, L, 2004) |
| "Retinal ischemia increased vitreous concentrations of glutamate and glycine." | 3.70 | Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. ( Bach, M; Feuerstein, TJ; Knörle, R; Lagrèze, WA, 1998) |
| "Treatment with memantine resulted in a significant reduction in RGC loss and NR1 expression in the eyes of rats COHT." | 1.34 | Expression of N-methyl-d-aspartate receptor 1 in rats with chronic ocular hypertension. ( Jung, SW; Kim, JH; Lee, NY; Park, CK, 2007) |
| "Chronic ocular hypertension was attained by laser photocoagulation of episcleral and limbal veins." | 1.31 | Neuroprotective effect of memantine in different retinal injury models in rats. ( Ruiz, G; Schwartz, M; Wheeler, LA; WoldeMussie, E; Yoles, E, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WoldeMussie, E | 3 |
| Yoles, E | 1 |
| Schwartz, M | 1 |
| Ruiz, G | 3 |
| Wheeler, LA | 1 |
| Hare, WA | 2 |
| Lai, RK | 1 |
| Ton, H | 2 |
| Chun, T | 1 |
| Wheeler, L | 2 |
| Weinreb, RN | 1 |
| Wijono, M | 1 |
| Feldmann, B | 1 |
| Zangwill, L | 1 |
| Kim, JH | 1 |
| Lee, NY | 1 |
| Jung, SW | 1 |
| Park, CK | 1 |
| Lagrèze, WA | 1 |
| Knörle, R | 1 |
| Bach, M | 1 |
| Feuerstein, TJ | 1 |
5 other studies available for memantine and Ocular Hypertension
| Article | Year |
|---|---|
Neuroprotective effect of memantine in different retinal injury models in rats.
Topics: Action Potentials; Animals; Cell Count; Cell Survival; Chronic Disease; Electrophysiology; Excitator | 2002 |
Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
Topics: Administration, Oral; Animals; Cell Count; Chronic Disease; Disease Models, Animal; Electroretinogra | 2004 |
Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures.
Topics: Administration, Oral; Animals; Cell Count; Cell Survival; Disease Models, Animal; Excitatory Amino A | 2004 |
Expression of N-methyl-d-aspartate receptor 1 in rats with chronic ocular hypertension.
Topics: Analysis of Variance; Animals; Cell Death; Disease Models, Animal; Excitatory Amino Acid Antagonists | 2007 |
Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia.
Topics: Animals; Cell Count; Chromatography, High Pressure Liquid; Disease Models, Animal; Excitatory Amino | 1998 |